IP Library Granted Patent US 9,463,237
Granted Patent B2
US 9,463,237 · App. 13/982,524 · Granted Oct 11, 2016

Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A viruses

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,463,237
App. No.
13/982,524
Granted
Oct 11, 2016
Kind
B2
Abstract

The present invention relates to recombinant viral vectors and methods of using the recombinant viral vectors to induce an immune response to influenza A viruses. The invention provides recombinant viral vectors based, for example, on the non-replicating modified vaccinia virus Ankara. When administered according to methods of the invention, the recombinant viral vectors are designed to be cross-protective and induce heterosubtypic immunity to influenza A viruses.

Claims (3)

1. A recombinant modified vaccinia virus Ankara (rMVA) comprising a first gene cassette encoding an influenza A headless hemagglutinin (hlHA) polypeptide of SEQ ID NO: 15 and a second gene cassette encoding influenza A nucleoprotein (NP).

2. A pharmaceutical composition comprising the rMVA of claim 1 .

3. A method of inducing a heterosubtypic immune response to influenza A viruses in an individual comprising administering a pharmaceutical composition comprising the rMVA of claim 1 to the individual.

Assignments (10)
CHANGE OF NAME Recorded Nov 20, 2025
From: RESILIENCE GOVERNMENT SERVICES, INC,
To: ALACHUA GOVERNMENT SERVICES, INC.
Reel/Frame 073279/0021 →
CHANGE OF NAME Recorded Sep 8, 2022
From: OLOGY BIOSERVICES, INC.
To: RESILIENCE GOVERNMENT SERVICES, INC.
Reel/Frame 061399/0903 →
RELEASE OF SECURITY INTEREST Recorded Aug 20, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: OLOGY BIOSERVICES, INC.; NANO ADM, LLC
Reel/Frame 053561/0070 →
CHANGE OF NAME Recorded Jan 23, 2019
From: NANOTHERAPEUTICS, INC.
To: OLOGY BIOSERVICES, INC.
Reel/Frame 049518/0666 →
SECURITY INTEREST Recorded May 1, 2018
From: OLOGY BIOSERVICES, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 046050/0305 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRESPONDENCE DATA PREVIOUSLY RECORDED ON REEL 037155 FRAME 0732. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 2, 2016
From: BAXALTA GMBH
To: NANOTHERAPEUTICS, INC.
Reel/Frame 038592/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2015
From: BAXALTA GMBH
To: NANOTHERAPEUTICS, INC.
Reel/Frame 037155/0732 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2015
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH
Reel/Frame 036502/0752 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH
Reel/Frame 036388/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2013
From: FALKNER, FALKO-GUNTER; SCHAFER, BIRGIT; HESSEL, ANNETT; BARRETT, P. NOEL; KREIL, THOMAS R.; EHRLICH, HARTMUT
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE S.A.
Reel/Frame 031365/0009 →